The 5th International Conference of Respiratory Diseases (CReD 2023)
View: 231
Website https://www.novevents.org/conference/CReD2023/ |
Edit Freely
Category Respiratory Diseases
Deadline: October 24, 2023 | Date: November 25, 2023-November 27, 2023
Venue/Country: Sanya, China
Updated: 2023-08-15 11:16:29 (GMT+9)
Call For Papers - CFP
The 5th International Conference of Respiratory Diseases (CReD 2023)Website:https://www.novevents.org/conference/CReD2023/
Date:November 25-27, 2023Venue:Sanya,ChinaOnline Registration Entrance:https://www.novevents.org/RegistrationSubmission/default.aspx?ConferenceID=1732
The 5th International Conference of Respiratory Diseases (CReD 2023) is scheduled to take place from November 25-27, 2023, in Sanya, China. Reflecting the urgency and relevance of today's respiratory health challenges, this conference will delve into pressing topics such as COVID-19, SARS, and other emerging viral respiratory infections. Alongside these current issues, the event will also explore Tuberculosis, distinctions between Active and Latent Tuberculosis, Acute Respiratory Infections, Adult and Child Lung Health, Lung Health and Tuberculosis, Medical Management of TB, Respiratory Medicine, Acute Respiratory Distress Syndrome (ARDS), Air Pollution, Occupational Lung Disease, Asthma, Emphysema, and other related subjects. Attendance Methods1. Full Paper submissionSubmit full paper ( Regular Attendance + Paper Publication + Presentation )You are invited to submit papers and participate in our academic exchange. One author will be invited to make an oral presentation and the paper will be published by peer-reviewed open access journal and submitted to CNKI and Google Scholar for indexing.2.Abstract submissionSubmit abstract ( Regular Attendance + Abstract + Presentation )You are welcome to submit abstract for oral presentation or poster presentation.3.Regular Attendance ( No Submission Required ) You're also welcome to attend our conference (without submitting full paper or abstract).Publication and PresentationPublication: All the accepted papers will be published by a peer-reviewed open access journal that can ensure the widest dissemination of your published workIndex: CNKI and Google ScholarNote: 1. If you want to present your research results but do NOT wish to publish a paper, you may simply submit an Abstract.2. The simple Abstract submission should include the title, contents, keywords, authors names, affiliations and emails. The length is suggested to be controlled within 1 page and no more than 2 pages.3. You will receive the review results within 3-5 working days after submission. If you do not get any notification within the time limit, please contact us as soon as possible.4. You are welcome to submit papers in Chinese and please contact us for more details.Contact UsEmail: rolin_zhang
163.com (Seminar.Group
hotmail.com)Whatsapp: 0086 13264702250Tel: +86 13264702250QQ: 1349406763WeChat: 3025797047 Official Account: Academic CommunicationsTwitter: conf_CommitteeTopics: Chronic Obstructive Pulmonary Disease (COPD)Pathology and Clinical Management of COPDGenetic Risk Factor of COPDDiagnosis and Treatment of COPDDepression and Anxiety in COPDAsthmaAcute Respiratory Distress SyndromeCOVID-19 Treatment and RecoveryCOVID-19 Vaccine and Lung ImmunopathologyLung Cancer Diagnosis & TreatmentRespiratory InfectionsChronic Respiratory DiseasesInnate Immunity and Lung FibrosisCardiopulmonary DisordersTuberculosisPneumoniaSleep ApneaCystic FibrosisIdiopathic Pulmonary FibrosisPulmonary Vascular DiseasePulmonary RehabilitationRespiratory Pharmacology & Care
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.